Praxair (PX) Stock Forecast & Price Target

Notice: This company has been marked as potentially delisted and may not be actively trading.

Praxair - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold
Based on 7 Analyst Ratings

Based on 7 Wall Street analysts who have issued ratings for Praxair in the last 12 months, the stock has a consensus rating of "Hold." Out of the 7 analysts, 4 have given a hold rating, and 3 have given a buy rating for PX.

Consensus Price Target

$10.71
6.13% Upside

High Forecast	$12.00
Average Forecast	$10.71
Low Forecast	$9.50

According to the 7 analysts' twelve-month price targets for Praxair, the average price target is $10.71. The highest price target for PX is $12.00, while the lowest price target for PX is $9.50. The average price target represents a forecasted upside of 6.13% from the current price of $10.10.

Type	Current Forecast 8/23/23 to 8/22/24	1 Month Ago 7/24/23 to 7/23/24	3 Months Ago 5/25/23 to 5/24/24	1 Year Ago 8/23/22 to 8/23/23
Consensus Rating	Hold	Moderate Buy	Moderate Buy	Buy
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	3 Buy rating(s)	3 Buy rating(s)	3 Buy rating(s)	6 Buy rating(s)
Hold	4 Hold rating(s)	3 Hold rating(s)	3 Hold rating(s)	0 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$10.71	$10.67	$10.67	$15.33
Forecasted Upside	6.13% Upside	19.67% Upside	19.67% Upside	30.89% Upside

Get Praxair Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for PX and its competitors with MarketBeat's FREE daily newsletter.

Ad Colonial Metals

Wanted Dead: Petrodollar

The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Russia, China and India have decided to abandon the petrodollar.

In answer to this issue, we have released a Special Report to the public.

PX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

PX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Praxair Stock vs. The Competition

Type	Praxair	Finance Companies	S&P 500
Consensus Rating Score	2.43	2.46	2.51
Consensus Rating	Hold	Hold	Moderate Buy
Predicted Upside	6.13% Upside	38.54% Upside	8.74% Upside
News Sentiment Rating	Neutral News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Action	Rating	Price Target	Upside/Downside on Report Date
8/21/2024	UBS Group 4 of 5 stars	Downgrade	Buy ➝ Neutral	$10.00 ➝ $10.50	+3.96%
8/14/2024	Morgan Stanley 3 of 5 stars	Boost Target	Equal Weight ➝ Equal Weight	$9.00 ➝ $10.00	+1.73%
8/12/2024	JPMorgan Chase & Co. 3 of 5 stars	Boost Target	Neutral ➝ Neutral	$9.50 ➝ $11.00	+18.28%
8/12/2024	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Overweight ➝ Overweight	$11.00 ➝ $12.00	+29.03%
8/12/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Overweight ➝ Overweight	$9.50 ➝ $11.00	+18.28%
8/9/2024	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Perform ➝ Market Perform	$9.00 ➝ $9.50	+8.20%
Get the Latest News and Ratings for PX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Praxair and its competitors with MarketBeat's FREE daily newsletter.
3/4/2024	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Outperform ➝ Outperform	$17.00 ➝ $11.00	+32.05%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 07:07 AM ET.

PX Forecast - Frequently Asked Questions

What is Praxair's forecast for 2024?: According to the research reports of 7 Wall Street equities research analysts, the average twelve-month stock price forecast for Praxair is $10.71, with a high forecast of $12.00 and a low forecast of $9.50.
Should I buy or sell Praxair stock right now?: 7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Praxair in the last year. There are currently 4 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" PX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in PX, but not buy additional shares or sell existing shares.
Does Praxair's stock price have much upside?: According to analysts, Praxair's stock has a predicted upside of 15.49% based on their 12-month stock forecasts.
Has Praxair been downgraded by Wall Street analysts recently?: Over the previous 90 days, Praxair's stock had 1 downgrade by analysts.
What analysts cover Praxair?: Praxair has been rated by research analysts at Barclays, JPMorgan Chase & Co., Keefe, Bruyette & Woods, Morgan Stanley, Stephens, and UBS Group in the past 90 days.
Do Wall Street analysts like Praxair more than its competitors?: Analysts like Praxair less than other "finance" companies. The consensus rating score for Praxair is 2.43 while the average consensus rating score for "finance" companies is 2.46. Learn more on how PX compares to other companies.